Brian Tanquilut

Anything you can share with us in terms of the growth rates for those, you know, tech operations?

Can you talk about the services that are driving the growth in that segment right now? Is it prior authorization? Or is there any other to call out on what's pushing Sonexus higher?

if tariffs are pushed through for drugs, should that be inflationary? Or is there anything I'm missing

How do you want us to think about the sequential move then from Q1 EBITDA to Q2

as I think about the rural benefit from one big beautiful bill, curious if you have any updated thoughts they finalized some of that

as I think of supplies cost, you guys have done a great job over the last few years keeping that fairly steady. At what point do those contracts reset?

how are we thinking about market share that you're seeing in the local market? And maybe also in the context of the payers are talking about high utilization rates

as we think about CapEx spend for the quarter, it was a little lower than typical range, like, 5.4% revenue. So just curious if there's anything there we need to be thinking about

the sustainability of demand in the access solutions portion of the business as it relates specifically to GLPs

Just curious any puts and takes you would call out or any nuances that we need to consider

was the beat in the quarter essentially already contemplated in your guide when you did Investor Day

is there any way you can talk about the trajectory there or to quantify how some of the tech and automation initiatives

how are you thinking about market share in that segment or that industry